Another study revealed that MRN-ATM-mediated DNA repair was inhibited by the downregulation of FOXM1, which subsequently increased the sensitivity of NPC cells to cisplatin [176]. This evidence concerns the gene FOXM1 and nasopharyngeal carcinoma.